FDA orders new Nonoxynol-9 warning

Dec 18, 2007

The U.S. Food and Drug Administration issued a final rule Tuesday requiring manufacturers of nonoxynol-9, or N9, to add a warning to the product's label.

The FDA said the warning must state the over-the-counter vaginal contraceptive and spermicidal product does not protect against infection by the human immunodeficiency virus that causes AIDS, nor does it protect against other sexually transmitted diseases.

Stand-alone spermicides include gels, foams, films, or inserts containing N9 that are used by themselves for contraception.

The federal agency said consumers can protect themselves from the transmission of STDs and HIV by practicing abstinence, being in a monogamous relationship with an uninfected partner and by using condoms consistently and correctly.

The FDA said it issued the rule to correct misconceptions that the chemical N9 protects against sexually transmitted diseases, including HIV infection.

In addition, the FDA is requiring the labels warn consumers that N9 in stand-alone vaginal contraceptives and spermicides can irritate the vagina and rectum, which may increase the risk of contracting HIV/AIDS from an infected partner.

Copyright 2007 by United Press International

Explore further: Xtoro approved for swimmer's ear

add to favorites email to friend print save as pdf

Related Stories

Sony hacking fallout puts all companies on alert

3 hours ago

Companies across the globe are on high alert to tighten up network security to avoid being the next company brought to its knees by hackers like those that executed the dramatic cyberattack against Sony Pictures ...

Recommended for you

Xtoro approved for swimmer's ear

13 hours ago

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

14 hours ago

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.